|
Dec 4
|
8 Forces That Shaped 2023—in Charts
|
|
Dec 4
|
Centene (CNC) Wins Contract From Arizona's Medicaid Agency
|
|
Dec 4
|
Roche (RHHBY) to Acquire Obesity Drug Maker Carmot for $2.7B
|
|
Dec 4
|
Altimmune (ALT) Rises 83% on Successful Phase II Obesity Study
|
|
Dec 4
|
Roche Strikes $3.1 Billion Deal for Obesity Drugmaker. It’s Hoping to Compete with Eli Lilly, Novo Nordisk.
|
|
Dec 4
|
Pfizer (PFE) Stock Down 5% as Obesity Drug Fails in Phase II
|
|
Dec 3
|
3 No-Brainer Growth Stocks to Buy in December
|
|
Dec 2
|
Everyone Is Talking About This Stock. Is It a Good Long-Term Option?
|
|
Dec 2
|
Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk?
|
|
Dec 1
|
Weight-Loss Stocks Are Getting Pricey. Time to Worry About a Bubble?
|
|
Dec 1
|
Pfizer drops plan for twice-daily obesity pill due to side effects
|
|
Dec 1
|
Will Novo Nordisk Be a Trillion-Dollar Stock by 2030?
|
|
Dec 1
|
UPDATE 3-EU watchdog seeks more data from GLP-1 drugmakers on suicidal thoughts
|
|
Dec 1
|
UPDATE 4-Pfizer drops twice-daily version of obesity pill over side effects
|
|
Nov 30
|
FDA Accepts Karuna's (KRTX) NDA Filing for Schizophrenia Drug
|
|
Nov 30
|
Is it a Good Idea to Invest in Harpoon (HARP) Stock Now?
|
|
Nov 30
|
Weight loss drugs likely to boost apparel stocks: Survey
|
|
Nov 30
|
Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
|
|
Nov 30
|
UPDATE 2-Novo Nordisk finds compounded Wegovy up to 33% impure, sues Florida pharmacies
|
|
Nov 29
|
Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine
|